131 related articles for article (PubMed ID: 2002806)
1. Induction of rat liver DNA alterations by chronic administration of peroxisome proliferators as detected by 32P-postlabeling.
Randerath E; Randerath K; Reddy R; Danna TF; Rao MS; Reddy JK
Mutat Res; 1991 Mar; 247(1):65-76. PubMed ID: 2002806
[TBL] [Abstract][Full Text] [Related]
2. 32P-postlabeling analysis of peroxisome proliferator-DNA adduct formation in rat liver in vivo and hepatocytes in vitro.
Gupta RC; Goel SK; Earley K; Singh B; Reddy JK
Carcinogenesis; 1985 Jun; 6(6):933-6. PubMed ID: 4006083
[TBL] [Abstract][Full Text] [Related]
3. Genotoxic effects of selected peroxisome proliferators.
Reisenbichler H; Eckl PM
Mutat Res; 1993 Apr; 286(2):135-44. PubMed ID: 7681524
[TBL] [Abstract][Full Text] [Related]
4. Contrasting hepatocytic peroxisome proliferation, lipofuscin accumulation and cell turnover for the hepatocarcinogens Wy-14,643 and clofibric acid.
Marsman DS; Goldsworthy TL; Popp JA
Carcinogenesis; 1992 Jun; 13(6):1011-7. PubMed ID: 1600604
[TBL] [Abstract][Full Text] [Related]
5. Incidence of pancreatic and testicular tumors in rats treated with ciprofibrate, a peroxisome proliferator.
Rao MS; Subbarao V
Cancer Lett; 1995 Nov; 97(2):185-8. PubMed ID: 7497461
[TBL] [Abstract][Full Text] [Related]
6. Altered hepatic eicosanoid concentrations in rats treated with the peroxisome proliferators ciprofibrate and perfluorodecanoic acid.
Wilson MW; Lay LT; Chow CK; Tai HH; Robertson LW; Glauert HP
Arch Toxicol; 1995; 69(7):491-7. PubMed ID: 8526745
[TBL] [Abstract][Full Text] [Related]
7. Increased resistance of peroxisome proliferator-induced hepatic lesions to iron overload in rats.
Rao MS; Subbarao V; Reddy JK
Cancer Lett; 1986 Jul; 32(1):33-9. PubMed ID: 3742486
[TBL] [Abstract][Full Text] [Related]
8. Treatment of rats with the peroxisome proliferator ciprofibrate results in increased liver NF-kappaB activity.
Li Y; Leung LK; Glauert HP; Spear BT
Carcinogenesis; 1996 Nov; 17(11):2305-9. PubMed ID: 8968042
[TBL] [Abstract][Full Text] [Related]
9. On the mechanism of the hepatocarcinogenicity of peroxisome proliferators.
Nilsson R; Beije B; Préat V; Erixon K; Ramel C
Chem Biol Interact; 1991; 78(2):235-50. PubMed ID: 2040027
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the hepatic responses to the short-term administration of ciprofibrate in several rat strain. Co-induction of microsomal cytochrome P-450 IVA1 and peroxisome proliferation.
Makowska JM; Anders C; Goldfarb PS; Bonner F; Gibson GG
Biochem Pharmacol; 1990 Sep; 40(5):1083-93. PubMed ID: 2390105
[TBL] [Abstract][Full Text] [Related]
11. Influence of peroxisome proliferators on phosphoprotein levels in human and rat hepatic-derived cell lines.
Passilly P; Jannin B; Latruffe N
Eur J Biochem; 1995 May; 230(1):316-21. PubMed ID: 7601116
[TBL] [Abstract][Full Text] [Related]
12. Reduction of the concentrations of prostaglandins E2 and F2alpha, and thromboxane B2 in cultured rat hepatocytes treated with the peroxisome proliferator ciprofibrate.
Leung LK; Glauert HP
Toxicol Lett; 1996 Jun; 85(3):143-9. PubMed ID: 8644126
[TBL] [Abstract][Full Text] [Related]
13. Species differences in hepatic peroxisome proliferation, cell replication and transforming growth factor-beta1 gene expression in the rat, Syrian hamster and guinea pig.
Lake BG; Rumsby PC; Price RJ; Cunninghame ME
Mutat Res; 2000 Mar; 448(2):213-25. PubMed ID: 10725474
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular DNA synthesis in rats given peroxisome proliferating agents: comparison of WY-14,643 to clofibric acid, nafenopin and LY171883.
Eacho PI; Lanier TL; Brodhecker CA
Carcinogenesis; 1991 Sep; 12(9):1557-61. PubMed ID: 1893515
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometric analysis of neoplastic nodules and hepatocellular carcinomas induced by ciprofibrate in the rat.
Goolsby CL; Rao MS
Br J Cancer; 1996 Jan; 73(2):197-202. PubMed ID: 8546906
[TBL] [Abstract][Full Text] [Related]
16. Species differences in the hepatic response to a potent peroxisome proliferator.
Makowska JM; Bonner FW; Goldfarb PS; Gibson GG
Biochem Soc Trans; 1989 Dec; 17(6):1072-3. PubMed ID: 2628085
[No Abstract] [Full Text] [Related]
17. Comparative induction of cytochrome P450IVA1 and peroxisome proliferation by ciprofibrate in the rat and marmoset.
Makowska JM; Bonner FW; Gibson GG
Arch Toxicol; 1991; 65(2):106-13. PubMed ID: 1905530
[TBL] [Abstract][Full Text] [Related]
18. Formation of 8-hydroxydeoxyguanosine in liver DNA of rats following long-term exposure to a peroxisome proliferator.
Kasai H; Okada Y; Nishimura S; Rao MS; Reddy JK
Cancer Res; 1989 May; 49(10):2603-5. PubMed ID: 2713844
[TBL] [Abstract][Full Text] [Related]
19. Effect of the peroxisome proliferators ciprofibrate and perfluorodecanoic acid on eicosanoid concentrations in rat liver.
Wilson MW; Leung LK; Hong JT; Glauert HP
Adv Exp Med Biol; 1997; 400A():439-45. PubMed ID: 9547588
[No Abstract] [Full Text] [Related]
20. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats.
Marsman DS; Cattley RC; Conway JG; Popp JA
Cancer Res; 1988 Dec; 48(23):6739-44. PubMed ID: 3180084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]